Detalhe da pesquisa
1.
Heart failure drug proscillaridin A targets MYC overexpressing leukemia through global loss of lysine acetylation.
J Exp Clin Cancer Res
; 38(1): 251, 2019 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31196146
2.
DNA Methylation-Targeted Drugs.
Cancer J
; 23(5): 270-276, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28926427
3.
Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome.
Mol Cancer Ther
; 16(2): 397-407, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27980103